Barry Ticho

2.2k total citations
27 papers, 1.5k citations indexed

About

Barry Ticho is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Physiology. According to data from OpenAlex, Barry Ticho has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Barry Ticho's work include Heart Failure Treatment and Management (7 papers), Adenosine and Purinergic Signaling (6 papers) and Polyomavirus and related diseases (5 papers). Barry Ticho is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Adenosine and Purinergic Signaling (6 papers) and Polyomavirus and related diseases (5 papers). Barry Ticho collaborates with scholars based in United States, United Kingdom and Germany. Barry Ticho's co-authors include Jonathan Underwood, Tarita Murray‐Thomas, Michel Komajda, Martín Cowie, Sandra Richman, Meena Subramanyam, Tatiana Plavina, Sophia Lee, William T. Abraham and Denise I. Campagnolo and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Communications.

In The Last Decade

Barry Ticho

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry Ticho United States	14	527	449	418	258	244	27	1.5k
Ari Mennander Finland	28	686 1.3×	106 0.2×	111 0.3×	778 3.0×	588 2.4×	122	2.6k
Jota Oyabu Japan	10	415 0.8×	99 0.2×	37 0.1×	192 0.7×	842 3.5×	13	1.8k
Xiao‐Ming Gao Australia	25	657 1.2×	118 0.3×	133 0.3×	96 0.4×	713 2.9×	53	1.7k
Bernhard J. Haubner Austria	16	656 1.2×	57 0.1×	124 0.3×	141 0.5×	804 3.3×	25	1.5k
Gunnar Klein Germany	28	1.8k 3.4×	82 0.2×	94 0.2×	284 1.1×	438 1.8×	69	2.5k
Mark P.V. Begieneman Netherlands	14	762 1.4×	81 0.2×	66 0.2×	95 0.4×	306 1.3×	25	1.4k
Jörg Heineke Germany	11	536 1.0×	79 0.2×	58 0.1×	55 0.2×	468 1.9×	15	1.4k
Yuji Matsumoto Japan	19	520 1.0×	54 0.1×	74 0.2×	147 0.6×	431 1.8×	84	1.4k
Masatoshi Kawana Japan	25	1.2k 2.3×	54 0.1×	85 0.2×	618 2.4×	482 2.0×	81	2.4k
Tadashi Isomura Japan	25	1.3k 2.5×	129 0.3×	85 0.2×	326 1.3×	497 2.0×	156	2.4k

Countries citing papers authored by Barry Ticho

Since Specialization

Citations

This map shows the geographic impact of Barry Ticho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Ticho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Ticho more than expected).

Fields of papers citing papers by Barry Ticho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Ticho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Ticho. The network helps show where Barry Ticho may publish in the future.

Co-authorship network of co-authors of Barry Ticho

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Ticho. A scholar is included among the top collaborators of Barry Ticho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Ticho. Barry Ticho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brunklaus, Andreas, et al.. (2026). Zorevunersen in Children and Adolescents with Dravet Syndrome. New England Journal of Medicine. 394(10). 969–982.

Sullivan, Joseph, Elaine Wirrell, Kelly G. Knupp, et al.. (2025). Natural History of Children and Adolescents With Dravet Syndrome. Neurology. 105(11). e214388–e214388.

Sullivan, Joseph, Elaine Wirrell, Kelly G. Knupp, et al.. (2022). Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome. Epilepsy & Behavior. 137(Pt A). 108955–108955. 5 indexed citations

Lim, Kian‐Huat, Han Zhou, Hyun Yong Jeon, et al.. (2020). Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression. Nature Communications. 11(1). 3501–3501. 138 indexed citations

Tofovic, Stevan P., Eman Salah, Glenn J. Smits, et al.. (2016). Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction. Journal of Pharmacology and Experimental Therapeutics. 356(2). 333–340. 15 indexed citations

Fox, Robert J., Bruce Cree, J. de Sèze, et al.. (2014). MS disease activity in RESTORE. Neurology. 82(17). 1491–1498. 144 indexed citations

Plavina, Tatiana, Meena Subramanyam, Gary Bloomgren, et al.. (2014). Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy. Annals of Neurology. 76(6). 802–812. 306 indexed citations

Kaufman, Michael D., Bruce Cree, J. de Sèze, et al.. (2014). Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE. Journal of Neurology. 262(2). 326–336. 17 indexed citations

Bozic, Carmen, et al.. (2013). Anti‐JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial. European Journal of Neurology. 21(2). 299–304. 68 indexed citations

10.

Li, Zhaoyang, et al.. (2011). Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects. International Journal of Clinical Pharmacology and Therapeutics. 49(9). 563–570. 2 indexed citations

11.

Abraham, William T., Juan M. Aranda, John Boehmer, et al.. (2010). Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study. Clinical and Translational Science. 3(5). 249–253. 27 indexed citations

12.

Li, Zhaoyang, Christopher TenHoor, Thomas Marbury, et al.. (2010). Clinical Pharmacokinetics of Tonapofylline: Evaluation of Dose Proportionality, Oral Bioavailability, and Gender and Food Effects in Healthy Human Subjects. The Journal of Clinical Pharmacology. 51(7). 1004–1014. 6 indexed citations

13.

Gottlieb, Stephen S., Barry Ticho, Aaron Deykin, et al.. (2010). Effects of BG9928, an Adenosine A₁Receptor Antagonist, in Patients With Congestive Heart Failure. The Journal of Clinical Pharmacology. 51(6). 899–907. 12 indexed citations

14.

Gill, Alan, et al.. (2009). Protective Effect of Tonapofylline (BG9928), an Adenosine A<sub>1</sub> Receptor Antagonist, against Cisplatin-Induced Acute Kidney Injury in Rats. American Journal of Nephrology. 30(6). 521–526. 22 indexed citations

15.

Greenberg, Barry, Ignatius Thomas, Steven Goldman, et al.. (2007). Effects of Multiple Oral Doses of an A1Adenosine Antagonist, BG9928, in Patients With Heart Failure. Journal of the American College of Cardiology. 50(7). 600–606. 53 indexed citations

16.

Cowie, Martín, Michel Komajda, Tarita Murray‐Thomas, Jonathan Underwood, & Barry Ticho. (2006). Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). European Heart Journal. 27(10). 1216–1222. 264 indexed citations

17.

Sun, Chao, Josée Dupuis, Barry Ticho, et al.. (2005). Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Human Genetics. 119(1-2). 113–125. 37 indexed citations

18.

Goffe, Bernard S., Kim Papp, David Gratton, et al.. (2005). An integrated analysis of thirteen trials summarizing thelong-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy. Clinical Therapeutics. 27(12). 1912–1921. 44 indexed citations

19.

Auchampach, John A., Xiaowei Jin, Jeannine Moore, et al.. (2004). Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs. Journal of Pharmacology and Experimental Therapeutics. 308(3). 846–856. 36 indexed citations

20.

Gottlieb, Stephen S., D. Craig Brater, Ignatius Thomas, et al.. (2002). BG9719 (CVT-124), an A ₁ Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy. Circulation. 105(11). 1348–1353. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact